Indications |
Oral Prostate cancer Adult: For androgen-dependent, inoperable and progressing cancer: 10 mg tid for at least 3 mth. Oral Moderate to severe vasomotor symptoms associated with menopause Adult: 1-2 mg/day adjusted as necessary; admin can be cyclical (3 wk on, 1 wk off) or continuous. In conjunction with a progestogen in women with uterus. Oral Prophylaxis of osteoporosis in postmenopausal women Adult: 0.5 mg/day in cyclic regimen (23 days on and 5 days off). Oral Hypogonadism Adult: 1-2 mg/day in a cyclic regimen for 3 wk on drug, followed by 1 wk drug-free. Intramuscular Prostate cancer Adult: As valerate: ≥30 mg every 1-2 wk. Intramuscular Moderate to severe vasomotor symptoms associated with menopause Adult: As cypionate: 1-5 mg every 3-4 wk; as valerate: 10-20 mg every 4 wk. In conjunction with a progestogen in women with uterus. Transdermal Moderate to severe vasomotor symptoms associated with menopause Adult: Each patch delivers 0.025 mg/day: Initially, apply once wkly, adjust dose as necessary to control symptoms. Attempt to taper or discontinue treatment at 3-6 mth intervals. In conjunction with a progestogen in women with uterus. Transdermal Prophylaxis of osteoporosis in postmenopausal women Adult: Each patch delivers 14 mcg/day. Apply patch once or twice wkly. Adjust dose by monitoring biochemical markers and bone mineral density. A 14-day course of progestogen is required in women with an intact uterus once every 6-12 mth. Intramuscular Hypogonadism Adult: As valerate: 10-20 mg every 4 wk. As cypionate: 1.5-2 mg mthly. Vaginal Vulvular and vaginal atrophy Adult: Insert 2-4 g/day of vag cream intravaginally for 2 wk, then reduce gradually to half the initial dose for 2 wk followed by a maintenance dose of 1 g 1-3 times/wk. Vaginal Postmenopausal vaginal atrophy Adult: Insert a vag ring containing 2 mg of estradiol and keep in place for 90 days. Vaginal Urogenital symptoms Adult: Insert a vag ring containing 2 mg of estradiol and keep in place for 90 days. Vaginal Atrophic vaginitis Adult: Initial: Insert 1 tab (20 mcg) once daily for 2 wk. Maintenance: Insert 1 tab twice wkly. Attempt to discontinue or taper medication at 3-6 mthly intervals. |
Contraindications |
Hypersensitivity; undiagnosed vag bleeding; thrombophloebitis or thromboembolic disorders; breast carcinoma except in selected patients being treated for metastatic disease; oestrogen-dependent tumor; porphyria; pregnancy. |
Warnings / Precautions |
Conditions exacerbated by fluid retention; hypercalcaemia, cerebrovascular diorders, coronary artery disease, gall bladder diseases; lipid effects; familial defects of lipoprotein metabolism. May increase BP, risk of venous thromboembolism, breast cancer, benign hepatic adenoma, endometrial cancer and size of preexisting uterine leiomyomata. Dosage should be reduced in hepatic impairment. Lactation. Child. |
Adverse Reactions |
GI disturbances, genitourinary changes, haematologic disorders, CV and CNS effects, endocrine and metabolic disorders, cholestatic jaundice, local skin reactions, chorea, contact lens intolerance, steeping of corneal curvature, pulmonary thromboembolism, carbohydrate intolerance. |
Drug Interactions |
CYP1A2 and CYP3A4 inducers e.g. aminoglutethimide, carbamazepine, phenobarbital, and rifampin may decrease the effects of estradiol. May enhance the effects of hydrocortisone and prednisolone when used together. See Below for More estradiol Drug Interactions |
Lab Interactions |
Reduced serum folate concentration and response to metyrapone test. May interfere with thyroid function and glucose tolerance tests. |
Food Interactions |
Folic acid absorption may be reduced. Ethanol increases the risk of osteoporosis; routine use of ethanol may also increase estrogen level and thus risk of breast cancer. Black cohosh, dong quai, red clover, saw palmetto, ginseng, St John's wort. |
Mechanism of Actions |
Estradiol is a naturally occurring oestrogen. Oestrogens are responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. They modulate the pituitary secretion of gonadotrophins, LH and FSH through a negative feedback system. Absorption: Readily absorbed from the GI tract and through the skin or mucous membranes. Distribution: Largely bound to plasma proteins. Metabolism: Partly metabolised hepatically to less active oestrogens such as estriol and estrone. |
Storage Conditions |
Intramuscular: Store at room temperature. Oral: Store at room temperature. Transdermal: Store at room temperature. Vaginal: Store at room temperature. |
ATC Classification |
G03CA03 - estradiol ; Belongs to the class of natural and semisynthetic estrogens used in estrogenic hormone preparations. |
Storage |
Intramuscular: Store at room temperature. Oral: Store at room temperature. Transdermal: Store at room temperature. Vaginal: Store at room temperature. |
Available As |
|
Estradiol
Post Review about Estradiol Click here to cancel reply.
Estradiol Containing Brands
Estradiol is used in following diseases
Drug - Drug Interactions of Estradiol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.